-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on Nutex Health, Raises Price Target to $300

Benzinga·05/15/2025 14:38:01
Listen to the news
Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $150 to $300.